Elizabeth Williams

Chief Financial Officer, Satellos Bioscienes

Ms. Williams has nearly 20 years of experience in biotech, working with publicly listed entities in both Canada and the United States. Ms. Williams is currently the CFO of Satellos Biosciences (TSX: MSCL) where she is responsible for all financial, legal, and investor relations functions of the Company. Prior to Satellos, Ms. Williams was the CFO of Medicenna Therapeutics (Nasdaq: MDNA) where she led the graduation of Medicenna from the TSX to Nasdaq and raised over $100M in capital during her tenure. Ms. Williams held senior roles at Aptose Biosciences Inc. (Nasdaq: APTO) and Ernst & Young LLP. Ms. Williams is a Chartered Professional Accountant (CPA) and Chartered Accountant (CA).